annual CFF:
-$211.72M-$161.56M(-322.11%)Summary
- As of today (August 16, 2025), AMRX annual cash flow from financing activities is -$211.72 million, with the most recent change of -$161.56 million (-322.11%) on December 31, 2024.
- During the last 3 years, AMRX annual CFF has fallen by -$73.60 million (-53.28%).
- AMRX annual CFF is now -140.61% below its all-time high of $521.39 million, reached on December 1, 2015.
Performance
AMRX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$41.69M-$2.52M(-6.44%)Summary
- As of today (August 16, 2025), AMRX quarterly cash flow from financing activities is -$41.69 million, with the most recent change of -$2.52 million (-6.44%) on June 30, 2025.
- Over the past year, AMRX quarterly CFF has dropped by -$6.60 million (-18.81%).
- AMRX quarterly CFF is now -108.91% below its all-time high of $467.98 million, reached on March 31, 2020.
Performance
AMRX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$234.40M-$6.60M(-2.90%)Summary
- As of today (August 16, 2025), AMRX TTM cash flow from financing activities is -$234.40 million, with the most recent change of -$6.60 million (-2.90%) on June 30, 2025.
- Over the past year, AMRX TTM CFF has increased by +$11.26 million (+4.58%).
- AMRX TTM CFF is now -146.27% below its all-time high of $506.60 million, reached on September 30, 2018.
Performance
AMRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMRX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -322.1% | -18.8% | +4.6% |
| 3 y3 years | -53.3% | -279.3% | -108.9% |
| 5 y5 years | -400.6% | +86.6% | -263.9% |
AMRX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -322.1% | at low | -279.3% | +58.7% | -304.5% | +6.8% |
| 5 y | 5-year | -256.7% | at low | -279.3% | +86.6% | -263.9% | +35.3% |
| alltime | all time | -140.6% | at low | -108.9% | +86.6% | -146.3% | +35.3% |
AMRX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$41.69M(+6.4%) | -$234.40M(+2.9%) |
| Mar 2025 | - | -$39.17M(-36.0%) | -$227.80M(+7.6%) |
| Dec 2024 | -$211.72M(+322.1%) | -$61.20M(-33.7%) | -$211.79M(-15.8%) |
| Sep 2024 | - | -$92.35M(+163.2%) | -$251.42M(+2.3%) |
| Jun 2024 | - | -$35.09M(+51.5%) | -$245.66M(+10.2%) |
| Mar 2024 | - | -$23.16M(-77.0%) | -$222.83M(+4.8%) |
| Dec 2023 | -$50.16M(-51.4%) | -$100.83M(+16.5%) | -$212.57M(+58.7%) |
| Sep 2023 | - | -$86.58M(+606.5%) | -$133.91M(+43.3%) |
| Jun 2023 | - | -$12.26M(-5.0%) | -$93.45M(+61.3%) |
| Mar 2023 | - | -$12.90M(-41.8%) | -$57.95M(-45.6%) |
| Dec 2022 | -$103.23M(-25.3%) | -$22.17M(-51.9%) | -$106.62M(-7.1%) |
| Sep 2022 | - | -$46.13M(-298.4%) | -$114.80M(+2.3%) |
| Jun 2022 | - | $23.25M(-137.8%) | -$112.23M(-35.3%) |
| Mar 2022 | - | -$61.57M(+102.9%) | -$173.54M(+25.6%) |
| Dec 2021 | -$138.12M(-202.2%) | -$30.35M(-30.3%) | -$138.12M(+16.0%) |
| Sep 2021 | - | -$43.55M(+14.4%) | -$119.05M(+31.8%) |
| Jun 2021 | - | -$38.07M(+45.6%) | -$90.31M(-75.1%) |
| Mar 2021 | - | -$26.15M(+131.8%) | -$362.32M(-374.9%) |
| Dec 2020 | $135.11M(-419.5%) | -$11.28M(-23.8%) | $131.81M(-2.9%) |
| Sep 2020 | - | -$14.81M(-95.2%) | $135.79M(-5.0%) |
| Jun 2020 | - | -$310.08M(-166.3%) | $143.00M(-67.8%) |
| Mar 2020 | - | $467.98M(-6512.4%) | $444.01M(-1068.8%) |
| Dec 2019 | -$42.29M | -$7.30M(-3.9%) | -$45.83M(-82.2%) |
| Sep 2019 | - | -$7.60M(-16.3%) | -$257.45M(+53.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$9.07M(-58.5%) | -$167.26M(-155.9%) |
| Mar 2019 | - | -$21.86M(-90.0%) | $299.06M(+4.0%) |
| Dec 2018 | $299.45M(-415.2%) | -$218.92M(-365.0%) | $287.68M(-43.2%) |
| Sep 2018 | - | $82.60M(-81.9%) | $506.60M(+19.5%) |
| Jun 2018 | - | $457.24M(-1475.3%) | $424.00M(-1375.3%) |
| Mar 2018 | - | -$33.25M | -$33.25M |
| Dec 2017 | -$95.02M(-124.3%) | - | - |
| Dec 2016 | $391.78M(-24.9%) | - | - |
| Dec 2015 | $521.39M(+3517.2%) | - | - |
| Dec 2014 | $14.41M(+60.8%) | - | - |
| Dec 2013 | $8.96M(-48.2%) | - | - |
| Dec 2012 | $17.32M(-18.7%) | - | - |
| Dec 2011 | $21.31M(-10.8%) | - | - |
| Dec 2010 | $23.90M(-416.1%) | - | - |
| Dec 2009 | -$7.56M(-88.4%) | - | - |
| Dec 2008 | -$65.08M(-729.6%) | - | - |
| Dec 2007 | $10.34M(<-9900.0%) | - | - |
| Dec 2006 | -$15.00K(-99.9%) | - | - |
| Dec 2005 | -$29.71M(-202.8%) | - | - |
| Dec 2003 | $28.91M(+477.5%) | - | - |
| Dec 2002 | $5.01M(-90.1%) | - | - |
| Dec 2001 | $50.69M(+61.5%) | - | - |
| Dec 2000 | $31.38M(+144.4%) | - | - |
| Dec 1999 | $12.84M(+749.3%) | - | - |
| Dec 1998 | $1.51M | - | - |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual CFF year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly CFF year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM CFF year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual cash flow from financing activities?
The current annual CFF of AMRX is -$211.72M
What is the all time high annual CFF for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual cash flow from financing activities is $521.39M
What is Amneal Pharmaceuticals, Inc. annual CFF year-on-year change?
Over the past year, AMRX annual cash flow from financing activities has changed by -$161.56M (-322.11%)
What is Amneal Pharmaceuticals, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of AMRX is -$41.69M
What is the all time high quarterly CFF for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly cash flow from financing activities is $467.98M
What is Amneal Pharmaceuticals, Inc. quarterly CFF year-on-year change?
Over the past year, AMRX quarterly cash flow from financing activities has changed by -$6.60M (-18.81%)
What is Amneal Pharmaceuticals, Inc. TTM cash flow from financing activities?
The current TTM CFF of AMRX is -$234.40M
What is the all time high TTM CFF for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM cash flow from financing activities is $506.60M
What is Amneal Pharmaceuticals, Inc. TTM CFF year-on-year change?
Over the past year, AMRX TTM cash flow from financing activities has changed by +$11.26M (+4.58%)